Stratification according to HGG-IMMUNO RPA model predicts outcome in a large group of patients with relapsed malignant glioma treated by adjuvant postoperative dendritic cell vaccination

Endpoints, patient selection, and biomarkers in the design of clinical trials for cancer vaccines

(2011) Marijo Bilusic et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers

(2011) L. H. Butterfield et al.   CLINICAL CANCER RESEARCH

Gene Expression Profile Correlates with T-Cell Infiltration and Relative Survival in Glioblastoma Patients Vaccinated with Dendritic Cell Immunotherapy

(2010) Robert M. Prins et al.   CLINICAL CANCER RESEARCH

The mean does not mean as much anymore: finding sub-groups for tailored therapeutics

(2010) Stephen J Ruberg et al.   Clinical Trials

Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study

(2010) Hilko Ardon et al.   JOURNAL OF NEURO-ONCOLOGY

Oncological patterns of care and outcome for 952 patients with newly diagnosed glioblastoma in 2004

(2010) L. Bauchet et al.   NEURO-ONCOLOGY

Dendritic Cell Therapy of High-Grade Gliomas

(2009) Stefaan Van Gool et al.   BRAIN PATHOLOGY

Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria

(2009) J. D. Wolchok et al.   CLINICAL CANCER RESEARCH

Immunogenicity and Antitumor Effects of Vaccination with Peptide Vaccine +/- Granulocyte-Monocyte Colony-Stimulating Factor and/or IFN- 2b in Advanced Metastatic Melanoma: Eastern Cooperative Oncology Group Phase II Trial E1696

(2009) J. M. Kirkwood et al.   CLINICAL CANCER RESEARCH

An epidermal growth factor receptor variant III-targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme

(2009) J. H. Sampson et al.   MOLECULAR CANCER THERAPEUTICS

Bevacizumab and irinotecan for recurrent oligodendroglial tumors

(2009) S. Taillibert et al.   NEUROLOGY

Bevacizumab and chemotherapy for recurrent glioblastoma: A single-institution experience

(2009) P. L. Nghiemphu et al.   NEUROLOGY

Vaccination Elicits Correlated Immune and Clinical Responses in Glioblastoma Multiforme Patients

(2008) C. J. Wheeler et al.   CANCER RESEARCH

Postoperative Adjuvant Dendritic Cell-Based Immunotherapy in Patients with Relapsed Glioblastoma Multiforme

(2008) S. De Vleeschouwer et al.   CLINICAL CANCER RESEARCH

Survival benefit of Boron neutron capture therapy for recurrent malignant gliomas

(2008) Shin-Ichi Miyatake et al.   JOURNAL OF NEURO-ONCOLOGY

Results of a phase I dendritic cell vaccine trial for malignant astrocytoma: potential interaction with adjuvant chemotherapy

(2007) David G. Walker et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma

(2007) Graziella Filippini et al.   NEURO-ONCOLOGY